Initiation of Immunomodulators
This IBD clinical care pathway provides a guideline for health care providers when initiating immunomodulators (thiopurines and methotrexate) and its use in adults with inflammatory bowel disease.
DOWNLOAD THE PDF
Disclaimer: Clinical care pathways are not a substitute for the personalized judgement and care of a trained healthcare professional.
Clare McCabe Woodrow (Alberta Health Services) and Dr. Natasha Bollegala (Women’s College Hospital & University of Toronto) led the review and update for the current version of this IBD Clinical Care Pathway.
Additional resources
For IBD providers
For people with IBD
Please provide us with feedback!
If you have used this clinical care pathway, please take a moment to fill out this survey to provide your valuable feedback.